![Podium mit Finalisten in Darmstadt bei der Übergabe der Auszeichnungsurkunden](https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
Pressemitteilungen
Willkommen im Pressebereich. Vertreter:innen der Presse schreiben uns bitte eine E-Mail, um in unseren Medienverteiler aufgenommen zu werden.
Filter Pressemitteilungen:
![Podium mit Finalisten in Darmstadt bei der Übergabe der Auszeichnungsurkunden](https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2023/11/11013127/IG-Akribion-Genomics-HGP23_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
![BioRiver Boost! 2023 Preisverleihung in Monheim](https://www.brain-biotech.com/sized/press/2023/09/11004282/20230922_BLP7144_2500px_PI_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2023/09/11004282/20230922_BLP7144_2500px_PI_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2023/09/11004282/20230922_BLP7144_2500px_PI_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2023/09/11004282/20230922_BLP7144_2500px_PI_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2023/09/11004282/20230922_BLP7144_2500px_PI_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2023/09/11004282/20230922_BLP7144_2500px_PI_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
Akribion-Genomics-Team der BRAIN Biotech AG gewinnt ersten Preis beim „BioRiver Boost!“ Start-up-Wettbewerb
BRAIN Biotech AG's Akribion-Genomics-Technologie erhält Patenterteilung für ihre bahnbrechende Nuklease G-dase E®
![Dr. Paul Scholz, Gewinner des VAAM-Innovationspreises 2023 © BRAIN Biotech AG](https://www.brain-biotech.com/sized/press/2023/09/11002661/Paul-Scholz_C-BRAIN-Biotech_5cd66764a524d79749292a9d1cb81cd6.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2023/09/11002661/Paul-Scholz_C-BRAIN-Biotech_9792761f206941f2ac1d970690010563.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2023/09/11002661/Paul-Scholz_C-BRAIN-Biotech_bef4f396f72a3c09aa1d296b4aaa85cc.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2023/09/11002661/Paul-Scholz_C-BRAIN-Biotech_dda02153f05587e32a95ae99d3111b40.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2023/09/11002661/Paul-Scholz_C-BRAIN-Biotech_fe146410472dbacb317440260feaad2d.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2023/09/11002661/Paul-Scholz_C-BRAIN-Biotech_aa0d4c2c9a9a4db450694ccd1a714bba.jpg 400w 300h)
Wissenschaftler der BRAIN Biotech AG erhält VAAM-Innovationspreis für die Entdeckung einer neuartigen CRISPR-Nuklease-Familie
BRAIN Biotech AG legt trotz anhaltend hohen F&E-Investitionen und schwierigeren gesamtwirtschaftlichen Rahmenbedingungen solide 9M-Zahlen vor
![Gruppenbild mit zwei Vertretern des Akribion Genomics Teams](https://www.brain-biotech.com/sized/press/2023/06/10999638/Science4Life_Final-Pitch-Team-Akribion_Genomics_Science4Life_e64595890892ef90bc6e36e9357f6ced.jpg 933w 700h, https://www.brain-biotech.com/sized/press/2023/06/10999638/Science4Life_Final-Pitch-Team-Akribion_Genomics_Science4Life_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2023/06/10999638/Science4Life_Final-Pitch-Team-Akribion_Genomics_Science4Life_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2023/06/10999638/Science4Life_Final-Pitch-Team-Akribion_Genomics_Science4Life_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
Akribion-Genomics-Team der BRAIN Biotech AG nimmt erfolgreich am Science4Life Venture Cup teil
![BRAIN Biotech Gebäude mit Jubiläumsbanner](https://www.brain-biotech.com/sized/press/2023/06/10999387/Gebaeude-mit-Banner_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2023/06/10999387/Gebaeude-mit-Banner_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2023/06/10999387/Gebaeude-mit-Banner_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2023/06/10999387/Gebaeude-mit-Banner_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2023/06/10999387/Gebaeude-mit-Banner_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2023/06/10999387/Gebaeude-mit-Banner_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
Unternehmensjubiläum BRAIN Biotech AG: 30 Jahre für eine biobasierte Zukunft
BRAIN Biotech AG bleibt mit Halbjahresergebnissen auf solidem Wachstumskurs und forciert die One-BioProducts-Strategie
![Fermentationsanlage](https://www.brain-biotech.com/sized/press/2023/05/10998626/Fermentation-plant-at-Biocatalysts-Ltd_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2023/05/10998626/Fermentation-plant-at-Biocatalysts-Ltd_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2023/05/10998626/Fermentation-plant-at-Biocatalysts-Ltd_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2023/05/10998626/Fermentation-plant-at-Biocatalysts-Ltd_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2023/05/10998626/Fermentation-plant-at-Biocatalysts-Ltd_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2023/05/10998626/Fermentation-plant-at-Biocatalysts-Ltd_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)
BRAIN Biotech AG übernimmt Biocatalysts Ltd. vollständig und beschleunigt die Umsetzung der One-BioProducts-Strategie
![Der Vorstand der BRAIN Biotech AG mit dem neuen und dem vorherigen Aufsichtsratsvorsitzenden](https://www.brain-biotech.com/sized/press/2023/03/10991102/BRAIN_HV_2023_Moelker_Kellinghusen_Majerus_Schneiders_03_web_e64595890892ef90bc6e36e9357f6ced.jpg 1480w 1110h, https://www.brain-biotech.com/sized/press/2023/03/10991102/BRAIN_HV_2023_Moelker_Kellinghusen_Majerus_Schneiders_03_web_30d69d7872214ab1e4014d8bba7db56e.jpg 1216w 912h, https://www.brain-biotech.com/sized/press/2023/03/10991102/BRAIN_HV_2023_Moelker_Kellinghusen_Majerus_Schneiders_03_web_86faee6772839d32b350fac4c27b7e3f.jpg 992w 744h, https://www.brain-biotech.com/sized/press/2023/03/10991102/BRAIN_HV_2023_Moelker_Kellinghusen_Majerus_Schneiders_03_web_b21614607ad61004f3e3f4cc9e45162c.jpg 768w 576h, https://www.brain-biotech.com/sized/press/2023/03/10991102/BRAIN_HV_2023_Moelker_Kellinghusen_Majerus_Schneiders_03_web_e87bcc7de5563807162e22d72e08cb4c.jpg 576w 432h, https://www.brain-biotech.com/sized/press/2023/03/10991102/BRAIN_HV_2023_Moelker_Kellinghusen_Majerus_Schneiders_03_web_7aaea36e1c69e77199618dc527ff476a.jpg 400w 300h)